Skip to content

Waiting for ethics approval A study for the safety, feasibility and cost-effectiveness of thulium laser system in the lung surgey

A study for the safety, feasibility and cost-effectiveness of thulium laser system in the lung surgey

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022629
Enrollment
Unknown
Registered
2019-04-19
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the tumor of lung

Interventions

experimental group:thulium laser
control group:staplers

Sponsors

China-Japan Friendship Hospital, Beijing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PART ONE 1. non-anatomic pulmonary wedge resection; 2. over 18 years old; 3. lung peripheral lesions with tumor size less than 2cm (including benign lesions, AAH, AIS MIA belonging to Tia-bN0Mo in stage, metastatic tumor, palliative surgery); 4. no other contraindications for surgery. PART TWO: 1. one-lobe pneumonectomy (malignant lung tumor); 2. over 18 years old; 3. the FEV1 > 1.5 L; 4. tumor stage was T1-3N0-1M0; 5. no other contraindications for surgery.

Exclusion criteria

Exclusion criteria: PART ONE 1. previous history of lung surgery in ipsilateral thoracic cavity; 2. have or have had COPD; 3. FEV1 < 40%; 4. cannot tolerate single lung ventilation; 5. poor general condition, incomplete liver and kidney function, or serious cardiovascular and cerebrovascular diseases; 6. coagulation dysfunction; 7. the chest cavity is widely adhered. PART TWO 1. cannot tolerate one - lung ventilation; 2. poor general condition, liver and kidney insufficiency, or serious cardiovascular and cerebrovascular diseases; 3. coagulation dysfunction; 4. extensive adhesion of the chest cavity; 5. the tumor was so extensive that lobectomy could not be performed; 6. patients who need tracheal anastomosis and vascular anastomosis.

Design outcomes

Primary

MeasureTime frame
Lung leakage time;

Countries

China

Contacts

Public ContactDeruo Liu

China-Japan Friendship Hospital, Beijing

deruoliu@vip.sina.com+86 13801186957

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026